Israel Englander’s Bio-Rad Laboratories Class A BIO Stock Holding History

Israel Englander’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-800	Closed	-$223K	–	5875
2026 Q1	$223K	Sell	800 -14,200	-95%	-$4.09M	﹤0.01%	5137
2025 Q4	$4.54M	Buy	+15,000	New	+$4.68M	﹤0.01%	3118
2024 Q4	–	Sell	-2,000	Closed	-$669K	–	5965
2024 Q3	$669K	Sell	2,000 -1,000	-33%	-$318K	﹤0.01%	4589
2024 Q2	$819K	Buy	3,000 +1,000	+50%	+$291K	﹤0.01%	4242
2024 Q1	$692K	Buy	+2,000	New	+$658K	﹤0.01%	4589
2023 Q2	–	Sell	-25,000	Closed	-$12M	–	6123
2023 Q1	$12M	Buy	+25,000	New	+$11.7M	0.01%	1783
2022 Q4	–	Sell	-25,000	Closed	-$10.4M	–	6577
2022 Q3	$10.4M	Buy	+25,000	New	+$12.5M	0.01%	2073
2022 Q2	–	Sell	-30,000	Closed	-$16.9M	–	6974
2022 Q1	$16.9M	Buy	30,000 +29,000	+2,900%	+$17.5M	0.01%	1568
2021 Q4	$756K	Buy	+1,000	New	+$748K	﹤0.01%	4673
2021 Q3	–	Sell	-20,000	Closed	-$12.9M	–	6785
2021 Q2	$12.9M	Buy	+20,000	New	+$12.2M	0.01%	1611
2020 Q1	–	Sell	-40,000	Closed	-$14.8M	–	3857
2019 Q4	$14.8M	Buy	+40,000	New	+$14.1M	0.02%	1055
2019 Q3	–	Sell	-12,000	Closed	-$3.75M	–	4167
2019 Q2	$3.75M	Buy	+12,000	New	+$3.59M	0.01%	1996
2016 Q2	–	Sell	-27,400	Closed	-$3.75M	–	3174
2016 Q1	$3.75M	Buy	+27,400	New	+$3.6M	0.01%	1420

Other funds holding BIO

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Israel Englander's BIO Position: Q2 2026 in Review

Israel Englander increased its Bio-Rad Laboratories Class A (BIO) stake by 1,718% in Q2 2026, buying an estimated $16.1M and bringing the position to 59,895 shares worth $17.6M. The position accounts for 0.01% of the portfolio, ranked #1736.

Israel Englander first reported a position in BIO in Q2 2013 and has held it in 53 quarters since. The position peaked at $219M in Q1 2023. 396 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

Israel Englander held 59,895 shares of Bio-Rad Laboratories Class A worth $17.6M as of Q2 2026.
Israel Englander bought 56,601 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $16.1M.
Bio-Rad Laboratories Class A made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1736 holding.
Israel Englander first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and has held it in 53 quarters since.
Israel Englander's Bio-Rad Laboratories Class A position peaked at $219M in Q1 2023.
396 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.